TR200001293T2 - Uykuda solunum durmasını tedavi etmek için mirtazapin kullanımı - Google Patents
Uykuda solunum durmasını tedavi etmek için mirtazapin kullanımıInfo
- Publication number
- TR200001293T2 TR200001293T2 TR2000/01293T TR200001293T TR200001293T2 TR 200001293 T2 TR200001293 T2 TR 200001293T2 TR 2000/01293 T TR2000/01293 T TR 2000/01293T TR 200001293 T TR200001293 T TR 200001293T TR 200001293 T2 TR200001293 T2 TR 200001293T2
- Authority
- TR
- Turkey
- Prior art keywords
- mirtazapine
- during sleep
- respiratory arrest
- treat respiratory
- arrest during
- Prior art date
Links
- RONZAEMNMFQXRA-UHFFFAOYSA-N mirtazapine Chemical compound C1C2=CC=CN=C2N2CCN(C)CC2C2=CC=CC=C21 RONZAEMNMFQXRA-UHFFFAOYSA-N 0.000 title abstract 3
- 229960001785 mirtazapine Drugs 0.000 title abstract 3
- 206010038669 Respiratory arrest Diseases 0.000 title 1
- RTHCYVBBDHJXIQ-MRXNPFEDSA-N (R)-fluoxetine Chemical compound O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=C(C(F)(F)F)C=C1 RTHCYVBBDHJXIQ-MRXNPFEDSA-N 0.000 abstract 1
- 229960002464 fluoxetine Drugs 0.000 abstract 1
- 230000029058 respiratory gaseous exchange Effects 0.000 abstract 1
- 229940124834 selective serotonin reuptake inhibitor Drugs 0.000 abstract 1
- 239000012896 selective serotonin reuptake inhibitor Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Mirtazapin terkibinin uykuda solunum durmasi hastaligini tedavide etkin oldugu bulunmustur. Mirtazapin, ihtiyari olarak, fluoksetin gibi bir SSRI ile birlikte kullanilir
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97203548 | 1997-11-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200001293T2 true TR200001293T2 (tr) | 2002-09-23 |
Family
ID=8228923
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2000/01293T TR200001293T2 (tr) | 1997-11-14 | 1998-11-13 | Uykuda solunum durmasını tedavi etmek için mirtazapin kullanımı |
Country Status (21)
Country | Link |
---|---|
US (1) | US6303595B1 (tr) |
EP (1) | EP1030667B1 (tr) |
JP (1) | JP2001522891A (tr) |
KR (1) | KR20010032009A (tr) |
CN (1) | CN1154495C (tr) |
AT (1) | ATE289816T1 (tr) |
AU (1) | AU737590B2 (tr) |
BR (1) | BR9815098A (tr) |
CA (1) | CA2309744A1 (tr) |
CZ (1) | CZ296282B6 (tr) |
DE (1) | DE69829202T2 (tr) |
DK (1) | DK1030667T3 (tr) |
ES (1) | ES2238781T3 (tr) |
HK (1) | HK1029932A1 (tr) |
HU (1) | HUP0100080A3 (tr) |
IL (2) | IL135825A0 (tr) |
NO (1) | NO20002218L (tr) |
PL (1) | PL192272B1 (tr) |
PT (1) | PT1030667E (tr) |
TR (1) | TR200001293T2 (tr) |
WO (1) | WO1999025356A1 (tr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1066036T3 (da) | 1998-02-27 | 2006-08-21 | Univ Illinois | Midler med serotoninrelateret aktivitet til behandling af sövnapnö |
US7160898B2 (en) * | 2001-12-14 | 2007-01-09 | Board Of Trustees Of The University Of Illinois | Pharmacological treatment for sleep apnea |
US20060241164A1 (en) * | 1998-02-27 | 2006-10-26 | The Board Of Trustees Of The University Of Illinoi | Pharmacological treatment for sleep apnea |
CZ302368B6 (cs) * | 2000-02-11 | 2011-04-13 | N.V. Organon | Farmaceutický prostredek |
US20020183306A1 (en) * | 2001-05-30 | 2002-12-05 | Pfizer Inc. | Combination treatment for sleep disorders including sleep apnea |
UA83666C2 (ru) | 2003-07-10 | 2008-08-11 | Н.В. Органон | Способ получения энантиомерно чистого миртазапина |
US7838029B1 (en) * | 2003-07-31 | 2010-11-23 | Watson Laboratories, Inc. | Mirtazapine solid dosage forms |
WO2005023767A2 (en) | 2003-09-10 | 2005-03-17 | Brentwood Equities Ltd. | Diastereomers of 4-aryloxy-3-hydroxypiperidines |
WO2006023703A2 (en) * | 2004-08-20 | 2006-03-02 | Cypress Bioscience, Inc. | Method for treating sleep related breathing disorders |
WO2006055854A2 (en) * | 2004-11-17 | 2006-05-26 | Cypress Bioscience, Inc. | Methods for reducing the side effects associated with mirtazapine treatment |
CN101132777A (zh) * | 2004-12-20 | 2008-02-27 | 科利吉姆制药公司 | 用于睡眠障碍的药物组合物 |
MX2009010967A (es) | 2007-04-11 | 2009-12-15 | Organon Nv | Un metodo para la preparacion de mirtazapina. |
WO2008157094A1 (en) * | 2007-06-13 | 2008-12-24 | Cypress Bioscience, Inc. | Improving the tolerability of mirtazapine and a second active by using them in combination |
WO2013188806A1 (en) * | 2012-06-14 | 2013-12-19 | The Regents Of The University Of Michigan | Sleep apnea treatment |
EP3261645B1 (en) | 2015-02-27 | 2021-04-28 | Dechra Limited | Stimulation of appetite, management of weight loss, and treatment of anorexia in dogs and cats |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4314081A (en) * | 1974-01-10 | 1982-02-02 | Eli Lilly And Company | Arloxyphenylpropylamines |
EP0517984A1 (en) * | 1991-06-11 | 1992-12-16 | Merrell Dow Pharmaceuticals Inc. | Derivatives of amide analogs of certain methano bridged quinolizines |
ATE333880T1 (de) * | 1995-10-24 | 2006-08-15 | Gruenenthal Gmbh | Montirelin zur verhinderung der schlafapnoe |
SE9504537D0 (sv) * | 1995-12-19 | 1995-12-19 | Jan Hedner | Sätt att behandla och diagnosticera andningsstörningar under sömn och medel för utförande av sättet |
IL121076A (en) * | 1996-06-19 | 2000-10-31 | Akzo Nobel Nv | Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors |
US6117855A (en) * | 1996-10-07 | 2000-09-12 | Merck Sharp & Dohme Ltd. | Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent |
-
1998
- 1998-11-13 KR KR1020007005121A patent/KR20010032009A/ko not_active Application Discontinuation
- 1998-11-13 DE DE69829202T patent/DE69829202T2/de not_active Expired - Fee Related
- 1998-11-13 DK DK98962348T patent/DK1030667T3/da active
- 1998-11-13 TR TR2000/01293T patent/TR200001293T2/tr unknown
- 1998-11-13 ES ES98962348T patent/ES2238781T3/es not_active Expired - Lifetime
- 1998-11-13 PL PL340467A patent/PL192272B1/pl not_active IP Right Cessation
- 1998-11-13 CA CA002309744A patent/CA2309744A1/en not_active Abandoned
- 1998-11-13 US US09/554,143 patent/US6303595B1/en not_active Expired - Fee Related
- 1998-11-13 AU AU17548/99A patent/AU737590B2/en not_active Ceased
- 1998-11-13 EP EP98962348A patent/EP1030667B1/en not_active Expired - Lifetime
- 1998-11-13 HU HU0100080A patent/HUP0100080A3/hu unknown
- 1998-11-13 BR BR9815098-7A patent/BR9815098A/pt not_active Application Discontinuation
- 1998-11-13 PT PT98962348T patent/PT1030667E/pt unknown
- 1998-11-13 CN CNB988111349A patent/CN1154495C/zh not_active Expired - Fee Related
- 1998-11-13 IL IL13582598A patent/IL135825A0/xx active IP Right Grant
- 1998-11-13 CZ CZ20001751A patent/CZ296282B6/cs not_active IP Right Cessation
- 1998-11-13 JP JP2000520789A patent/JP2001522891A/ja active Pending
- 1998-11-13 WO PCT/EP1998/007330 patent/WO1999025356A1/en not_active Application Discontinuation
- 1998-11-13 AT AT98962348T patent/ATE289816T1/de not_active IP Right Cessation
-
2000
- 2000-04-25 IL IL135825A patent/IL135825A/en not_active IP Right Cessation
- 2000-04-28 NO NO20002218A patent/NO20002218L/no not_active Application Discontinuation
-
2001
- 2001-02-05 HK HK01100800A patent/HK1029932A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN1154495C (zh) | 2004-06-23 |
EP1030667A1 (en) | 2000-08-30 |
PT1030667E (pt) | 2005-06-30 |
CA2309744A1 (en) | 1999-05-27 |
CZ296282B6 (cs) | 2006-02-15 |
IL135825A0 (en) | 2001-05-20 |
CN1278731A (zh) | 2001-01-03 |
ATE289816T1 (de) | 2005-03-15 |
HUP0100080A3 (en) | 2002-05-28 |
PL340467A1 (en) | 2001-02-12 |
HUP0100080A2 (hu) | 2001-08-28 |
BR9815098A (pt) | 2000-10-10 |
AU737590B2 (en) | 2001-08-23 |
AU1754899A (en) | 1999-06-07 |
CZ20001751A3 (cs) | 2000-10-11 |
NO20002218L (no) | 2000-05-12 |
KR20010032009A (ko) | 2001-04-16 |
DK1030667T3 (da) | 2005-06-20 |
ES2238781T3 (es) | 2005-09-01 |
PL192272B1 (pl) | 2006-09-29 |
NO20002218D0 (no) | 2000-04-28 |
US6303595B1 (en) | 2001-10-16 |
DE69829202T2 (de) | 2005-07-21 |
JP2001522891A (ja) | 2001-11-20 |
EP1030667B1 (en) | 2005-03-02 |
HK1029932A1 (en) | 2001-04-20 |
WO1999025356A1 (en) | 1999-05-27 |
IL135825A (en) | 2006-12-31 |
DE69829202D1 (de) | 2005-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200001293T2 (tr) | Uykuda solunum durmasını tedavi etmek için mirtazapin kullanımı | |
TR200103233T2 (tr) | Antikolinerjik etkili bileşik ve ß-mimetikler bazında yeni ilaç bileşimleri. | |
TR200102308T2 (tr) | Yüzey etkinliğine sahip yapay peptidler ve bunların yapay yüzey aktif maddelerin hazırlanmasında kullanımı | |
NZ515392A (en) | Respiratory syncytial virus replication inhibitors | |
DE69830660D1 (de) | Behandlung von atemstillstand im schlaf | |
ATE241358T1 (de) | Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen | |
ATE207351T1 (de) | Verwendung vonmodafinil zur behandlung von atemstillstand im schlaf und zentral erregten atembeschwerden | |
ATE497809T1 (de) | Myricitrin verbindungen zur behandlung von schlafstörungen | |
DE60008143D1 (de) | Lipoxin-a4 und deren analoge zur behandlung von trockenen augen | |
SE9701161D0 (sv) | New use I | |
EE04661B1 (et) | Viirus-indutseeritud ssteemse oki ja hingamispuudulikkuse reverseerimine lmfotoksiin-beeta raja blokeerimise abil | |
EE200200337A (et) | Uued ühendid ning nende kasutamine | |
NZ528164A (en) | Use of flumazenil to produce a medicament for the treatment of cocaine dependency | |
DE69840637D1 (de) | Zusammensetzungen zur steigerung der effizienz von impfstoffen unter verwendung von chemokinen | |
MXPA02012911A (es) | Compuestos de rutenio (ii) para el uso en terapia del cancer. | |
ATE297739T1 (de) | Endothelin-antagonisten zur behandlung von herzversagen | |
ZA9711468B (en) | New use of comt inhibitors | |
HK1048263A1 (en) | Medicaments that contain xenogenic oligo-or/and polyribonucleotides. | |
NO970607D0 (no) | Anordning av selegilin i behandling av epileptiske tilstander | |
ATE268170T1 (de) | Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenz | |
PT910398E (pt) | Metodo de estimulacao de cilios | |
DE60203895D1 (de) | Verwendung von n-acetyl-d-glucosamin bei der herstellung eines arzneimittels zur unterdrückung der nebenwirkungen von strahlentherapie und chemotherapie | |
BR0015424A (pt) | Análogos de ácido hidroxieicosatetraenóico e, métodos de seu uso em tratamento de distúrbios de olho seco | |
DE69210737D1 (de) | Verwendung von L-2-Oxothiazolidine-4-Carboxylate zur Herstellung eines Arzneimittels zur Behandlung von latenten HIV-Infektionen | |
BR0012380A (pt) | 2-amino-benzoxazinonas para o tratamento de vìrus do herpes simples |